Subscribe to RSS
DOI: 10.1055/a-1727-5895
Comorbidities in Children with COVID-19 and MIS-C/PIMS-TS and Risk Factors for Hospitalization, Severe Disease, Intensive Care and Death
Komorbidität bei Kindern mit COVID-19 und MIS-C/PIMS-TS und Risikofaktoren für Hospitalisierung, schweren Krankheitsverlauf, Intensivtherapie und TodAbstract
This narrative review sums up data from the SARS-CoV-2-pandemia on preexisting disease/underlying conditions/comorbidities and risk factors in children for severe COVID-19 and MIS-C/PIMS-TS as well as hospitalization and mortality. Young infants and adolescents are at highest risk of hospital and PICU admission. Two or more comorbidities rather than single entities pose a risk for more severe courses of SARS-CoV-2 infection in children. Asthma and malignancy do not increase complication rates. MIS-C/PIMS-TS is not associated with any specific underlying disease.
Zusammenfassung
Der narrative Review fasst vorliegende Daten zu zugrundeliegenden Erkrankungen und Komorbiditäten und Risikofaktoren für schweren Verlauf von COVID-19 und MIS-C/PIMS-TS bei Kindern, erfasst als Hospitalisierung, Aufnahme auf einer Intensivstation und Tod bei Kindern, zusammen. Säuglinge und Jugendliche haben das höchste Risiko für Hospitalisierungen und Aufnahme auf einer Intensivstation. Mehr als eine Grunderkrankung/Komorbidität erhöht das Risiko für einen schweren Verlauf einer SARS-CoV-2-Infektion bei Kindern. In den vorliegenden Daten findet sich keine Assoziation eines schweren Verlaufes mit Asthma bronchiale und onkologischen Erkrankungen. Es findet sich keine Assoziation von Grunderkrankungen und Komorbiditäten mit MIS-C/PIMS-TS.
Schlüsselwörter
COVID-19 - MIS-C/PIMS-TS - Kinder - schwere Erkrankung - Risikofaktoren - Grunderkrankungpublished online 2022Publication History
Article published online:
03 February 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart,
Germany
-
References
- 1 Alkan G, Sert A, Oz SKT. et al. Clinical features and outcome of MIS-C patients: an experience from Central Anatolia. Clinical rheumatology 2021; 1-11 DOI: 10.1007/s10067-021-05754-z.
- 2 Armann J, Doenhardt M, Hufnagel M. et al. Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry. medRxiv 2021; 2021.2006.2007.21258488 DOI: 10.1101/2021.06.07.21258488.
- 3 Armann JP, Diffloth N, Simon A. et al. Hospital Admission in Children and Adolescents With COVID-19. Deutsches Arzteblatt international 2020; 117: 373-374 DOI: 10.3238/arztebl.2020.0373.
- 4 Bellino S, Punzo O, Rota MC. et al. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy. Pediatrics 2020; 146 DOI: 10.1542/peds.2020-009399.
- 5 Bhopal SS, Bagaria J, Olabi B. et al. Children and young people remain at low risk of COVID-19 mortality. The Lancet Child & adolescent health 2021; 5: e12-e13 DOI: 10.1016/s2352-4642(21)00066-3.
- 6 Calvo C, Alcolea S, Casas I. et al. A 14-year Prospective Study of Human Coronavirus Infections in Hospitalized Children: Comparison With Other Respiratory Viruses. The Pediatric infectious disease journal 2020; 39: 653-657 DOI: 10.1097/inf.0000000000002760.
- 7 Carbajal R, Lorrot M, Levy Y. et al. Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID-19 pandemic in France. Acta paediatrica (Oslo, Norway: 1992) 2021; 110: 922-932 DOI: 10.1111/apa.15667.
- 8 de Ceano-Vivas M, Martín-Espín I, Del Rosal T. et al. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children. Archives of disease in childhood 2020; 105: 808-809 DOI: 10.1136/archdischild-2020-319366.
- 9 Gaborieau L, Delestrain C, Bensaid P. et al. Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris. Journal of clinical medicine 2020; 9 DOI: 10.3390/jcm9072227.
- 10 Garazzino S, Lo Vecchio A, Pierantoni L. et al. Epidemiology, Clinical Features and Prognostic Factors of Pediatric SARS-CoV-2 Infection: Results From an Italian Multicenter Study. Front Pediatr 2021; 9: 649358 DOI: 10.3389/fped.2021.649358.
- 11 Giacomet V, Barcellini L, Stracuzzi M. et al. Gastrointestinal Symptoms in Severe COVID-19 Children. The Pediatric infectious disease journal 2020; 39: e317-e320 DOI: 10.1097/inf.0000000000002843.
- 12 Gill PJ, Ashdown HF, Wang K. et al. Identification of children at risk of influenza-related complications in primary and ambulatory care: a systematic review and meta-analysis. The Lancet Respiratory medicine 2015; 3: 139-149 DOI: 10.1016/s2213-2600(14)70252-8.
- 13 Götzinger F, Santiago García B, Noguera A. et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health 2020; 4 DOI: 10.1016/s2352-4642(20)30177-2.
- 14 Harwood R, Tan H, Camara N. et al. Which children and young people are at higher risk of severe disease and death after SARS-CoV-2 infection: a systematic review and individual patient meta-analysis. 2021
- 15 Kim TY, Kim EC, Agudelo AZ. et al. COVID-19 hospitalization rate in children across a private hospital network in the United States: COVID-19 hospitalization rate in children. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2021; DOI: 10.1016/j.arcped.2021.07.004.
- 16 Kompaniyets L, Agathis NT, Nelson JM. et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA network open 2021; 4: e2111182 DOI: 10.1001/jamanetworkopen.2021.11182.
- 17 Korkmaz MF, Türe E, Dorum BA. et al. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study. Journal of Korean medical science 2020; 35: e236 DOI: 10.3346/jkms.2020.35.e236.
- 18 Maltezou HC, Magaziotou I, Dedoukou X. et al. Children and Adolescents With SARS-CoV-2 Infection: Epidemiology, Clinical Course and Viral Loads. The Pediatric infectious disease journal 2020; 39: e388-e392 DOI: 10.1097/inf.0000000000002899.
- 19 Mehta NS, Mytton OT, Mullins EWS. et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2020; 71: 2469-2479 DOI: 10.1093/cid/ciaa556.
- 20 Moraleda C, Serna-Pascual M, Soriano-Arandes A. et al. Multi-inflammatory Syndrome in Children Related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Spain. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2021; 72: e397-e401 DOI: 10.1093/cid/ciaa1042.
- 21 Ouldali N, Yang DD, Madhi F. et al. Factors Associated With Severe SARS-CoV-2 Infection. Pediatrics 2021; 147 DOI: 10.1542/peds.2020-023432.
- 22 Pang J, Boshier FAT, Alders N. et al. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children. Pediatrics 2020; 146 DOI: 10.1542/peds.2020-019844.
- 23 Parri N, Lenge M, Cantoni B. et al. COVID-19 in 17 Italian Pediatric Emergency Departments. Pediatrics 2020; 146 DOI: 10.1542/peds.2020-1235.
- 24 Shi T, Pan J, Katikireddi SV. et al. Risk of COVID-19 hospital admission among children aged 5-17 years with asthma in Scotland: a national incident cohort study. The Lancet Respiratory Medicine 2021; DOI: 10.1016/s2213-2600(21)00491-4.
- 25 Shi T, Vennard S, Mahdy S. et al. Risk factors for RSV associated acute lower respiratory infection poor outcome and mortality in young children: A systematic review and meta-analysis. The Journal of infectious diseases 2021; DOI: 10.1093/infdis/jiaa751.
- 26 Storch-de-Gracia P, Leoz-Gordillo I, Andina D. et al. Clinical spectrum and risk factors for complicated disease course in children admitted with SARS-CoV-2 infection. Anales de pediatria 2020; 93: 323-333 DOI: 10.1016/j.anpede.2020.07.005.
- 27 Swann OV, Holden KA, Turtle L. et al. Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ (Clinical research ed) 2020; 370: m3249 DOI: 10.1136/bmj.m3249.
- 28 Tagarro A, Epalza C, Santos M. et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA pediatrics 2020; DOI: 10.1001/jamapediatrics.2020.1346.
- 29 Wang X, Li Y, Mei X. et al. Global hospital admissions and in-hospital mortality associated with all-cause and virus-specific acute lower respiratory infections in children and adolescents aged 5–19 years between 1995 and 2019: a systematic review and modelling study. BMJ global health 2021; 6 DOI: 10.1136/bmjgh-2021-006014.
- 30 Whittaker E, Bamford A, Kenny J. et al. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. Jama 2020; 324: 259-269 DOI: 10.1001/jama.2020.10369.
- 31 Yayla BCC, Aykac K, Ozsurekci Y. et al. Characteristics and Management of Children With COVID-19 in a Tertiary Care Hospital in Turkey. Clinical pediatrics 2021; 60: 170-177 DOI: 10.1177/0009922820966306.
- 32 Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. The Pediatric infectious disease journal 2020; 39: 355-368 DOI: 10.1097/inf.0000000000002660.